Effects of Lysyl oxidase genetic variants on the susceptibility to rhegmatogenous retinal detachment and proliferative vitreoretinopathy

Inflammation

Volumn 36, Issue 4, 2013, Pages 839-844

  Yu, Honghua ^a   Li, Tao ^b   Zou, Xiulan ^a   Yuan, Ling ^c   Hu, Jie ^b   Xu, Zhe ^a   Peng, Lianghong ^a   Zhang, Chu ^a   Zou, Yuping ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

lysyl oxidase; polymorphism; proliferative vitreoretinopathy; rhegmatogenous retinal detachment

Indexed keywords

GENOMIC DNA; PROTEIN LYSINE 6 OXIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOX GENE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROMOTER REGION; RETINA DETACHMENT; RETINA SURGERY; SINGLE NUCLEOTIDE POLYMORPHISM; VITREORETINOPATHY;

BASE SEQUENCE; CASE-CONTROL STUDIES; EYE DISEASES, HEREDITARY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN-LYSINE 6-OXIDASE; RETINAL DETACHMENT; SEQUENCE ANALYSIS, DNA; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84880304735     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9610-6     Document Type: Article

References (27)

1. Machemer, R.; T.M. Aaberg, H.M. Freeman, A.R. Irvine, J.S. Lean, and R.M. Michels. 1991. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112: 159-165.
2. de la Rúa, E.; J.C. Pastor, I. Fernández, M.R. Sanabria, J. García-Arumí, V. Martínez-Castillo, et al. 2008. Non-complicated retinal detachment management: Variations in 4 years. Retina 1 project; report 1. Br J Ophthalmol 92: 523-525.
3. Miller, B.; H. Miller, R. Patterson, and S.J. Ryan. 1986. Retinal wound healing. Cellular activity at the vitreoretinal interface. Arch Ophthalmol 104: 281-285.
4. Scott J.D. 1989. Pathogenesis of PVR with analysis of events leading to recurrent retinal detachment. In Proliferative vitreoretinopathy, eds. Heimann K and Wiedemann P. Heidelberg: Kaden.
5. Pastor, J.C. 1998. Proliferative vitreoretinopathy: An overview. Surv Ophthalmol 43: 3-18.
6. Wiedemann, P. 1992. Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol 36: 373-384.
7. Zacks, D.N.; Y. Han, Y. Zeng, and A. Swaroop. 2006. Activation of signaling pathways and stress-response genes in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 47: 1691-1695.
8. Retina Society Terminology Committee. 1983. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90: 121-125.
9. Lucero, H.A.; and H.M. Kagan. 2006. Lysyl oxidase: An oxidative enzyme and effector of cell function. Cell Mol Life Sci 63: 2304-2316.
10. Ito, H.; H. Akiyama, H. Iguchi, K. Iyama, M. Miyamoto, K. Ohsawa, et al. 2001. Molecular cloning and biological activity of a novel lysyl oxidase-related gene expressed in cartilage. J Biol Chem 276: 24023-24029.
11. Cardoso, W.V. 2001. Molecular regulation of lung development. Annu Rev Physiol 63: 471-494.
12. Gilad, G.M.; H.M. Kagan, and V.H. Gilad. 2005. Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci Lett 376: 210-214.
13. Wilmarth, K.R.; and J.R. Froines. 1992. In vitro and in vivo inhibition of lysyl oxidase by aminopropionitriles. J Toxicol Environ Health 37: 411-423.
14. Erler, J.T.; K.L. Bennewith, M. Nicolau, N. Dornhofer, C. Kong, Q.T. Le, et al. 2006. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226.
15. Erler, J.T.; and A.J. Giaccia. 2006. Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res 66: 10238-10241.
16. Li, X.; W. Shi, G. Yu, L. Lin, B. Yang, J. Li, et al. 2012. Interleukin-4-590 T/C polymorphism influences the susceptibility to nonsmall cell lung cancer. DNA Cell Biol 31: 797-800.
17. Song, B.; Y. Liu, J. Liu, X. Song, Z. Wang, M. Wang, et al. 2011. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis. Respiration 82: 439-444.
18. Min, C.; Z. Yu, K.H. Kirsch, Y. Zhao, S.R. Vora, P.C. Trackman, et al. 2009. A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer. Cancer Res 69: 6685-6693.
19. Yoon, J.H.; J.K. Park, Y.H. Kang, Y.K. Park, S.W. Nam, J.Y. Lee, et al. 2011. Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population. APMIS 119: 762-768.
20. Oue, N.; Y. Mitani, J. Motoshita, S. Matsumura, K. Yoshida, H. Kuniyasu, et al. 2006. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 106: 1250-1259.
21. Hollosi, P.; J.K. Yakushiji, K.S. Fong, K. Csiszar, and S.F. Fong. 2009. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. Int J Cancer 125: 318-327.
22. Li, A.F.; N. Tane, and S. Roy. 2004. Fibronectin overexpression inhibits trabecular meshwork cell monolayer permeability. Mol Vis 10: 750-757.
23. Chronopoulos, A.; A. Tang, E. Beglova, P.C. Trackman, and S. Roy. 2010. High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: Mechanism for compromised extracellular matrix barrier function. Diabetes 59: 3159-3166.
24. Tsuchiya, M.I.; H. Okuda, Y. Takaki, M. Baba, S.I. Hirai, S. Ohno, et al. 2005. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones. Oncol Rep 13: 1033-1041.
25. Kannan, K.; N. Amariglio, G. Rechavi, J. Jakob-Hirsch, I. Kela, N. Kaminski, et al. 2001. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20: 2225-2234.
26. Rost, T.; V. Pyritz, I.O. Rathcke, T. Gorogh, A.A. Dunne, and J.A. Werner. 2003. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer Res 23: 1565-1573.
27. Liu, Y.; B. Lv, Z. He, Y. Zhou, C. Han, G. Shi, et al. 2012. Lysyl oxidase polymorphisms and susceptibility to osteosarcoma. PLoS One 7: e41610. doi: 10.1371/journal.pone.0041610.